CY1118684T1 - Διαδερμικα επιθεματα χαμηλης δοσης με υψηλη απελευθερωση φαρμακου - Google Patents

Διαδερμικα επιθεματα χαμηλης δοσης με υψηλη απελευθερωση φαρμακου

Info

Publication number
CY1118684T1
CY1118684T1 CY20171100272T CY171100272T CY1118684T1 CY 1118684 T1 CY1118684 T1 CY 1118684T1 CY 20171100272 T CY20171100272 T CY 20171100272T CY 171100272 T CY171100272 T CY 171100272T CY 1118684 T1 CY1118684 T1 CY 1118684T1
Authority
CY
Cyprus
Prior art keywords
interderative
rates
drug release
low dosage
high drug
Prior art date
Application number
CY20171100272T
Other languages
English (en)
Inventor
Ildiko Terebesi
Christian Zurth
Hannes-Friedrich Ulbrich
Original Assignee
Bayer Intellectual Property Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1118684(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Intellectual Property Gmbh filed Critical Bayer Intellectual Property Gmbh
Publication of CY1118684T1 publication Critical patent/CY1118684T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Abstract

Η παρούσα εφεύρεση αφορά στον τομέα των τεχνικών για φαρμακοτεχνικές μορφές. Η εφεύρεση παρέχει μια φαρμακευτική σύνθεση χαμηλής δόσης για τη διαδερμική χορήγηση ορμονών, κατά προτίμηση μιας προγεστερόνης, όπως η Γεστοδένη, και ενός οιστρογόνου, κατά προτίμηση Αιθινυλοιστραδιόλη ώστε να επιτευχθούν προφίλ συγκέντρωσης πλάσματος αποτελεσματικά για την παρεμπόδιση της ωορρηξίας σε μια γυναίκα.
CY20171100272T 2010-09-06 2017-03-01 Διαδερμικα επιθεματα χαμηλης δοσης με υψηλη απελευθερωση φαρμακου CY1118684T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10175498 2010-09-06
EP11155469 2011-02-22
PCT/EP2011/065261 WO2012031999A2 (en) 2010-09-06 2011-09-05 Low-dose transdermal patches with high drug release
EP11757811.2A EP2613772B1 (en) 2010-09-06 2011-09-05 Low-dose transdermal patches with high drug release

Publications (1)

Publication Number Publication Date
CY1118684T1 true CY1118684T1 (el) 2017-07-12

Family

ID=44653287

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100272T CY1118684T1 (el) 2010-09-06 2017-03-01 Διαδερμικα επιθεματα χαμηλης δοσης με υψηλη απελευθερωση φαρμακου

Country Status (19)

Country Link
US (1) US8671945B2 (el)
EP (1) EP2613772B1 (el)
CN (1) CN103189064B (el)
AR (1) AR082906A1 (el)
CY (1) CY1118684T1 (el)
DK (1) DK2613772T3 (el)
ES (1) ES2617334T3 (el)
HK (1) HK1186968A1 (el)
HR (1) HRP20170292T1 (el)
HU (1) HUE031326T2 (el)
LT (1) LT2613772T (el)
ME (1) ME02618B (el)
PL (1) PL2613772T3 (el)
PT (1) PT2613772T (el)
RS (1) RS55681B1 (el)
SI (1) SI2613772T1 (el)
TW (1) TW201215393A (el)
UY (1) UY33593A (el)
WO (1) WO2012031999A2 (el)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
CH674618A5 (el) 1987-04-02 1990-06-29 Ciba Geigy Ag
DE58909570D1 (de) 1988-10-27 1996-02-22 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
JPH06502419A (ja) 1990-10-29 1994-03-17 アルザ・コーポレーション 経皮避妊製剤、方法及びデバイス
US5512292A (en) 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE19527925C2 (de) * 1995-07-29 1997-07-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
DE19827732A1 (de) 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
TWI287455B (en) 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
ES2375105T3 (es) * 2001-06-18 2012-02-24 Noven Pharmaceuticals, Inc. Administración mejorada de medicamentos en los sistemas transdérmicos.
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
BRPI0407615B8 (pt) * 2003-02-21 2021-05-25 Bayer Ip Gmbh sistema terapêutico transdérmico estável à radiação ultravioleta
WO2005021229A2 (en) 2003-08-25 2005-03-10 Bfs Diversified Products, Llc Method and apparatus to monitor the compressive strength of insulation boards
EP1541136A1 (de) 2003-12-10 2005-06-15 Schering AG UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
EA011160B1 (ru) 2003-12-12 2009-02-27 Шеринг Акциенгезельшафт Композиция для трансдермальной доставки гормонов без необходимости использования агентов, усиливающих проникновение, и ее применения
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
WO2010042152A2 (en) 2008-10-06 2010-04-15 Mylan Technologies, Inc. Amorphous rotigotine transdermal system

Also Published As

Publication number Publication date
CN103189064B (zh) 2015-08-12
DK2613772T3 (en) 2017-03-06
EP2613772B1 (en) 2016-12-14
ES2617334T3 (es) 2017-06-16
UY33593A (es) 2012-04-30
HUE031326T2 (hu) 2017-07-28
CN103189064A (zh) 2013-07-03
SI2613772T1 (sl) 2017-03-31
EP2613772A2 (en) 2013-07-17
ME02618B (me) 2017-06-20
US20120073578A1 (en) 2012-03-29
WO2012031999A2 (en) 2012-03-15
WO2012031999A3 (en) 2012-08-02
AR082906A1 (es) 2013-01-16
LT2613772T (lt) 2017-03-27
RS55681B1 (sr) 2017-07-31
TW201215393A (en) 2012-04-16
HK1186968A1 (en) 2014-03-28
US8671945B2 (en) 2014-03-18
PL2613772T3 (pl) 2017-06-30
HRP20170292T1 (hr) 2017-04-21
PT2613772T (pt) 2017-03-06

Similar Documents

Publication Publication Date Title
AR117670A2 (es) Modulador del receptor de andrógeno y sus usos
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
CY1119435T1 (el) Σκευασμα για αντισωμα εναντι- αλφα4βητα7
GT201500021A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
BR112014031824A2 (pt) terapias de reposição hormonal transdérmica
CY1114988T1 (el) Βενζοδιαζεπινη αναστολεας bromodomain
BR112014018439A8 (pt) Terapias de reposição de hormônio transdérmica
BR112014018953A8 (pt) Derivados de lupano triterpenoide e uso farmacêutico dos mesmos
CO7160008A2 (es) Derivados de estra- 1,3,5(10),16- tetraeno 3-sustituidos, métodos para su preparación, prepara-ciones farmaceúticas que los contienen, así como su uso para la preparación de medicamentos
BR112013004440A2 (pt) método para administração parenteral de uma composição, composição farmacêutica para administração parenteral, kit e sistema farmacêutico para administração parenteral
CY1123398T1 (el) Συνθεση συνδυασμου
CR20120657A (es) Derivados de 6,7-dihidro-5h-benzo[7]anulenos, métodos para su preparación, preparaciones farmacéuticas que los contienen y su uso para la preparación de medicamentos
CY1122626T1 (el) Κορτικοστεροειδες που περιεχει τις συνθεσεις των δισκιων που διασπωνται απο το στομα για την ηωσινοφιλικη οισοφαγιτιδα
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
CY1120488T1 (el) Υγρη φαρμακευτικη συνθεση
CR20110704A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
PH12017501769A1 (en) Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone
WO2016040462A3 (en) Formulations and methods for treatment of metabolic syndrome
BR102012028120B8 (pt) Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento
CY1118684T1 (el) Διαδερμικα επιθεματα χαμηλης δοσης με υψηλη απελευθερωση φαρμακου
BR112018068370A2 (pt) composição farmacêutica em dose fixa contendo amlodipina, candesartan cilexetil e hidroclorotiazida para o tratamento de hipertensão
WO2016014680A3 (en) Oral transmucosal compositions including aromatase inhibitors for low testosterone levels in men
BR112014018426A8 (pt) Composição e dispositivo para administração transdérmica, e, método para administrar uma progestina